Report
Carine Maciol

Ageas : Coveted diversified footprint and recurring strong performance. Buy recommendation confirmed.

Publication date 06/04/2022 09:08 - Writing date 06/04/2022 08:59 - - - - - Equity data - Reco : Neutral - Target : 50 EUR - Equity analyst: Cor Kluis - - 8 - - / - / - Q1 2022 results: 11/05/2022 - Q2 2022 results: 10/08/2022 - Q3 2022 results: 09/11/2022 - - - - Ageas has a diversified business profile, buoyed by a solid base with recurring performances in Belgium (albeit under pressure from weather-related uncertainties), an expanding franchise in Portugal...
Underlying
Ageas SA/NV

Ageas is an insurance company engaged in providing a range of life and non-life products distributed through a variety of channels. Co. focuses on helping its customers to mitigate risks related to property, casualty, life and pensions. Co. serves its customers through a combination of wholly owned subsidiaries, equity associates and partnerships, with financial institutions and distributors in Belgium, the U.K., Luxembourg, Italy, Portugal, Turkey, France, China, Malaysia, India, Thailand and Hong Kong. Co. is organized into five operating segments: Belgium, U.K., Continental Europe, Asia, and General Account.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Carine Maciol

Other Reports on these Companies
Other Reports from Oddo BHF
Emira Sagaama ... (+3)
  • Emira Sagaama
  • Robert Jan Vos
  • Thomas Zlowodzki
Jeremy Garnier ... (+2)
  • Jeremy Garnier
  • Thomas Zlowodzki
Florent Laroche-Joubert
  • Florent Laroche-Joubert

ResearchPool Subscriptions

Get the most out of your insights

Get in touch